Metabolic signatures of Besnoitia besnoiti-infected endothelial host cells and blockage of key metabolic pathways indicate high glycolytic and glutaminolytic needs of the parasite

Parasitol Res. 2016 May;115(5):2023-34. doi: 10.1007/s00436-016-4946-0. Epub 2016 Feb 6.

Abstract

Besnoitia besnoiti is an obligate intracellular and emerging coccidian parasite of cattle with a significant economic impact on cattle industry. During acute infection, fast-proliferating tachyzoites are continuously formed mainly in endothelial host cells of infected animals. Given that offspring formation is a highly energy and cell building block demanding process, the parasite needs to exploit host cellular metabolism to meet its metabolic demands. Here, we analyzed the metabolic signatures of B. besnoiti-infected endothelial host cells and aimed to influence parasite proliferation by inhibitors of specific metabolic pathways. The following inhibitors were tested: fluoro 2-deoxy-D-glucose and 2-deoxy-D-glucose (FDG, DG; inhibitors of glycolysis), 6-diazo-5-oxo-L-norleucin (DON; inhibitor of glutaminolysis), dichloroacetate (DCA; inhibitor of pyruvate dehydrogenase kinase which favorites channeling of glucose carbons into the TCA cycle) and adenosine-monophosphate (AMP; inhibitor of ribose 5-P synthesis). Overall, B. besnoiti infections of bovine endothelial cells induced a significant and infection rate-dependent increase of glucose, lactate, glutamine, glutamate, pyruvate, alanine, and serine conversion rates which together indicate a parasite-triggered up-regulation of glycolysis and glutaminolysis. Thus, addition of DON, FDG, and DG into the cultivation medium of B. besnoiti infected endothelial cells led to a dose-dependent inhibition of parasite replication (4 μM DON, 99.5 % inhibition; 2 mM FDG, 99.1 % inhibition; 2 mM DG, 93 % inhibition; and 8 mM DCA, 71.9 % inhibition). In contrast, AMP had no significant effects on total tachyzoite production up to a concentration of 20 mM. Together, these data may open new strategies for the development of therapeutics for B. besnoiti infections.

Keywords: 2-Deoxy-D-glucose; Coccidia; DON; Glutaminolysis; Glycolysis; Metabolic signature.

MeSH terms

  • Animals
  • Antibodies, Protozoan / metabolism
  • Cattle
  • Cattle Diseases / metabolism
  • Cattle Diseases / parasitology*
  • Coccidiosis / metabolism
  • Coccidiosis / veterinary*
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / parasitology*
  • Glutamine / metabolism*
  • Glycolysis
  • In Vitro Techniques
  • Metabolic Networks and Pathways / drug effects
  • Sarcocystidae / immunology
  • Sarcocystidae / metabolism*

Substances

  • Antibodies, Protozoan
  • Glutamine